Summary & Overview
CPT 33362: Transcatheter Aortic Valve Replacement via Open Femoral Artery
CPT code 33362 represents transcatheter aortic valve implantation (TAVI/TAVR) in which an aortic valve prosthesis is inserted through the lumen of a catheter using an open femoral artery approach. This procedural code captures catheter-based aortic valve replacement when direct femoral arterial exposure is used, an important distinction for coding, billing, and clinical documentation across hospitals and cardiac centers. Nationally, TAVR procedures are a major component of structural heart interventions and carry implications for payment, resource allocation, and perioperative care pathways.
Key payers covered in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical service represented by the code, typical site-of-service considerations, and the payer landscape relevant to this procedure. The publication outlines benchmarks, common billing modifiers (where data is available), and contextual clinical notes that clarify when this code applies versus other transcatheter aortic valve codes. It also highlights policy and billing considerations that affect reimbursement and documentation requirements for hospitals and cardiac service lines.
The report is designed for coding professionals, hospital revenue leaders, and clinicians involved in structural heart programs who need a clear reference for CPT code 33362, its clinical context, and how it aligns with national payer coverage patterns and administrative practices.
Billing Code Overview
CPT code 33362 describes transcatheter aortic valve replacement (TAVR/TAVI) performed by inserting an aortic valve prosthesis through the lumen of a catheter using an open femoral artery approach. The service is a catheter-based aortic valve replacement delivered via the femoral artery with direct arterial exposure.
Service Type: Transcatheter aortic valve replacement (TAVR/TAVI) via open femoral artery approach
Typical Site of Service: Hospital operating room or hybrid cardiac catheterization suite
Clinical & Coding Specifications
Clinical Context
An 82-year-old male with symptomatic, severe aortic stenosis (progressive dyspnea on exertion, New York Heart Association Class III symptoms) and multiple comorbidities that increase surgical risk is evaluated for transcatheter aortic valve implantation using an open femoral artery approach (TAVR/TAVI, CPT 33362). Pre-procedure workup includes transthoracic and transesophageal echocardiography to confirm valve anatomy and severity, gated CT angiography of the aorta and iliofemoral vessels to assess vessel size and calcification, and a multidisciplinary heart team review (interventional cardiology, cardiothoracic surgery, cardiac anesthesia). The patient is admitted on the day of procedure to an operating room or hybrid catheterization suite; general anesthesia or monitored anesthesia care is provided. An open surgical exposure of the common femoral artery is performed, a sheath is placed, and a transcatheter aortic valve prosthesis is advanced and deployed across the native aortic valve under fluoroscopic and echocardiographic guidance. Post-deployment assessment includes angiography and echocardiography to confirm valve position and function. Hemostasis is achieved at the surgical femoral arteriotomy prior to transfer to a post-anesthesia care unit and then a monitored inpatient setting for 24–72 hour observation.
-
Service Type: Invasive cardiac valve replacement (transcatheter aortic valve implantation) via open femoral artery access.
-
Typical Site of Service: Operating room or hybrid catheterization laboratory with surgical capability and postoperative inpatient monitoring.